Investigation of the role of mesenchymal stem cells on keratoplasty rejection

Chinese Journal of Ophthalmology

Volumn 48, Issue 8, 2012, Pages 733-738

  Zhang, Xiao Min ^a   Jiao, Chun Na ^a   Jia, Zhe ^a   Ren, Xin Jun ^a   Li, Xiao Rong ^a   Zhao, Shao Zhen ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Corneal transplantation; Graft rejection; Mesenchymal stem cells

Indexed keywords

ANIMAL; ARTICLE; CORNEA TRANSPLANTATION; DISEASE MODEL; FEMALE; GRAFT REJECTION; LEWIS RAT; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; RAT; WISTAR RAT;

ANIMALS; CORNEAL TRANSPLANTATION; DISEASE MODELS, ANIMAL; FEMALE; GRAFT REJECTION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RATS; RATS, INBRED LEW; RATS, WISTAR;

EID: 84867591251     PISSN: 04124081     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0412-4081.2012.08.013     Document Type: Article

References (25)

1. Lam H, Dana M R. Corneal graft rejection. International Ophthalmology clinics, 2009, 49:31-41.
2. Panda A, Vanathi M, Kumar A, et al. Corneal Graft Rejection. Surv Ophthalmol, 2007, 52:375-396.
3. Tabbara K F. Pharmacologic strategies in the prevention and treatment of corneal transplant rejection. Int Ophthalmol, 2008, 28:223-232.
4. Zhang X, Ren X, Li G, et al. Mesenchymal Stem Cells Ameliorate Experimental Autoimmune Uveoretinitis by Comprehensive Modulation of systemic autoimmunity. Invest Ophthalmol Vis Sci, 2011, 52:3143-3152.
5. Zhang X, Jiao C, Zhao S. Role of mesenchymal stem cells in immunological rejection of organ transplantation. Stem Cell Rev, 2009, 5:402-409.
6. 2008, 44: 1050-1054.
7. 2006, 42:246-250.
8. Larkin D F, Calder V L, Lightman S L. Identification and characterization of cells infiltrating the graft and aqueous humor in rat corneal graft rejection. Clin Exp Immunol, 1997, 107: 381-391.
9. Plumas J, Chapot L, Richard M J. Mesenchymal stem cells induce apoptosis of activated T cells. Leukemia, 2005, 19: 1597-1604.
10. Corcione A, Benvenuto F, Ferreti E. Human mesenchymal stem cells modulate B-cell functions. Blood, 2006, 107: 367-372.
11. Spaggiari G M, Capobianco A, Becchetti S, et al. Mesenchymal stem cell natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood, 2006, 107: 1484-1490.
12. Nauta A J, Kruisselbrink A B, Lurvink E, et al. Mesenchymal stem cells inhibit generation and function of both CD34-derived and monocyte-derived dendritic cells. J Immunol, 2006, 177: 2080-2087.
13. Le Blanc K, Tammik L, Sundberg B, et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol, 2003, 57:11-20.
14. Patel S A, Sherman L, Munoz J, et al. Immunological properties of mesenchymal stem cells and clinical implications. Arch Immunol Ther Exp, 2008, 56:1-8.
15. Petit F, Minns A B, Nazzal J A, et al. Prolongation of skin allograft survival after neonatal injection of donor bone marrow and epidermal cells. Plast Reconstr Surg, 2004, 113: 270-276.
16. Wan C D, Cheng R, Wang H B, et al. Immunomodulatory effects of mesenchymal stem cells derived from adipose tissues in a rat orthotopic liver transplantation model. Hepatobiliary Pancreat Dis Int, 2008, 7: 29-33.
17. Solari M G, Srinivasan S, Boumaza I, et al. Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia. Journal of Autoimmunity, 2009, 32: 116-124.
18. Popp F C, Renner P, Eggenhofer E, et al. Mesenchymal stem cells as immunomodulators after liver transplantation. Liver Transplantation, 2009, 15: 1192-1198.
19. Casiraghi F, Noris M, Remuzzi G. Immunomodulatory effects of mesenchymal stromal cells in solid organ transplantation. Curr Opin Organ Transplant, 2010 Sep 24. [Epub ahead of print]
20. Perico N, Casiraghi F, Introna M, et al. Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility. Clin J Am Soc Nephrol, 2011, 6:412-422.
21. Comite P, Cobianchi L, Avanzini M A, et al. Isolation and ex vivo expansion of bone marrow-derived porcine mesenchymal stromal cells: potential for application in an experimental model of solid organ transplantation in large animals. Transplant Proc, 2010, 42:1341-1343.
22. Sato K, Ozaki K, Mori M, et al. Mesenchymal stromal cells for graft-versus-host disease: basic aspects and clinical outcomes. J Clin Exp Hematop, 2010, 50:79-89.
23. Daya S M, Bell R W, Habib N E, et al. Clinical and pathologic findings in human keratolimbal allograft rejection. Cornea, 2000, 19: 443-450.
24. Oh J Y, Kim M K, Ko J H, et al. Rat allogeneic mesenchymal stem cells did not prolong the survival of corneal xenograft in a pig-to-rat model. Vet Ophthalmol, 2009, 12 Suppl 1:35-40.
25. Jones S, Horwood N, Cope A, et al. The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells. J Immunol, 2007, 179: 2824-2831.